Lexicon Pharmaceuticals
LXRX
#7142
Rank
A$0.76 B
Marketcap
A$2.11
Share price
-1.41%
Change (1 day)
109.15%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.29. In 2024 the company made an earnings per share (EPS) of A-$0.96 an increase over its 2023 EPS that were of A-$1.20.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-68.64%
2024A-$0.96-20%
2023A-$1.2031.15%
2022A-$0.92-0%
2021A-$0.9210.91%
2020A-$0.83-145.08%
2019A$1.84-206.09%
2018A-$1.73-5.74%
2017A-$1.84-10.95%
2016A-$2.062640%
2015A-$0.07527-96.34%
2014A-$2.05-2.53%
2013A-$2.11-9.09%
2012A-$2.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
A-$115.49 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$65.40-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.94 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.09-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$26.11-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.81 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$6.73-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.60-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.13 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA